Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05364606 · ClinicalTrials.gov registry record
Patient Specific Talus Spacer Post Approval Study
A clinical trial of Avascular Necrosis of the Talus, sponsored by Paragon 28.
- Recruiting
- Registry status
- 50
- Enrollment target
- 6
- Study locations
NCT05364606: Recruiting study of Avascular Necrosis of the Talus, sponsored by Paragon 28.
NCT05364606 is a study of Avascular Necrosis of the Talus that is actively recruiting participants, run by Paragon 28. The registered enrollment target is 50 participants. The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05364606, a study of Avascular Necrosis of the Talus, is actively recruiting participants, sponsored by Paragon 28.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
Primary Outcome
Clinically Significant Improvement in Pain on the Visual Analog Scale (VAS) at 5 years compared to baseline on the 0 to 100mm scale. A lower score will indicate an improvement in pain.
Conditions Studied
Interventions
- DEVICE Patient Specific Talus Spacer
Study Locations (6)
California
- Redwood Orthopaedics - Santa Rosa
Indiana
- Fort Wayne Orthopedics - Fort Wayne
Maryland
- Mercy Institute for Foot & Ankle Reconstruction - Baltimore
North Carolina
- Duke Orthopeadics Arringdon - Morrisville
South Carolina
- Medical University of South Carolina - Charleston
Texas
- UT Physicians Orthopedics - Pearland - Pearland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-07-08 |
| Est. Completion | 2029-11-30 |
What NCT05364606 shows while recruiting
NCT05364606 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Avascular Necrosis of the Talus appearing as the primary indexed condition, and to 1 intervention - of which Patient Specific Talus Spacer is the first listed.
NCT05364606 lists 6 locations in 6 states (California, Indiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT05364606 about?
NCT05364606 is a clinical study titled "Patient Specific Talus Spacer Post Approval Study". Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
What is the current status of trial NCT05364606?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-07-08. Estimated completion is 2029-11-30.
What conditions does trial NCT05364606 study?
This clinical trial studies the following conditions: Avascular Necrosis of the Talus.
What interventions are being tested in trial NCT05364606?
The interventions under investigation include: Patient Specific Talus Spacer (DEVICE).
Who is sponsoring clinical trial NCT05364606?
This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05364606 being conducted?
This trial has 6 study locations across California, Indiana, Maryland, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avascular Necrosis of the Talus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI